Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Melda Cömert"'
Autor:
Melda Cömert, Tuba Bulduk, Bilge Uğur, Murat Yıldırım, Selim Sayın, Alparslan Merdin, Ebru Kılıç Güneş, Elifcan Aladağ Karakulak, Meltem Aylı
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S33-S34 (2021)
Objective: The response of elderly patients with acute myeloid leukemia (AML) to standard induction therapy is quite poor due to higher frequency of adverse genomic features, increased resistance to treatments, comorbidities and performance status. B
Externí odkaz:
https://doaj.org/article/8b18364c97ed43b6bd1a68128e0a4314
Autor:
Demet Çekdemir, Serkan Güvenç, Füsun Özdemirkıran, Ali Eser, Tayfur Toptaş, Vildan Özkocaman, Handan Haydaroğlu Şahin, Esra Ermiş Turak, Ramazan Esen, Melda Cömert, Sevil Sadri, Müzeyyen Aslaner, Bahar Uncu Ulu, Abdullah Karakuş, Derya Selim Batut, İnci Alacacıoğlu, Demet Aydın, Atakan Tekinalp, Sinem Namdaroğlu, Funda Ceran
Publikováno v:
Turkish Journal of Hematology, Vol 36, Iss 4, Pp 230-237 (2019)
Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP). Materials and Methods: A total of 285 chronic ITP patient
Externí odkaz:
https://doaj.org/article/f62f596267fc4188a4b3ff19c7f174b1
Autor:
Nur Soyer, Burçin Tezcanlı Kaymaz, Melda Cömert Özkan, Çağdaş Aktan, Ali Şahin Küçükaslan, Fahri Şahin, Buket Kosova, Güray Saydam
Publikováno v:
Turkish Journal of Hematology, Vol 34, Iss 2, Pp 174-178 (2017)
We aimed to determine the genotype distribution, allele frequency, and prognostic impact of IDH1/2, TET2, and ASXL1 single nucleotide polymorphisms (SNPs) in myeloproliferative neoplasms (MPNs). TET2 (rs763480), ASXL1 (rs2208131), and IDH1 (rs1155413
Externí odkaz:
https://doaj.org/article/1e5f44a876e8402bae9972ea539c83ef
Autor:
Nur Soyer, İbrahim C Haznedaroğlu, Melda Cömert, Demet Çekdemir, Mehmet Yılmaz, Ali Ünal, Gülsüm Çağlıyan, Oktay Bilgir, Osman İlhan, Füsun Özdemirkıran, Emin Kaya, Fahri Şahin, Filiz Vural, Güray Saydam
Publikováno v:
Turkish Journal of Hematology, Vol 34, Iss 1, Pp 27-33 (2017)
Objective: Chronic myeloproliferative neoplasms (CMPNs) that include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) are Philadelphia-negative malignancies characterized by a clonal proliferation of one or seve
Externí odkaz:
https://doaj.org/article/93b0b3f3366447f1a13c05b2c903eb80
Autor:
Anıl Tombak, Burcu Boztepe, Naci Tiftik, Melda Cömert, Ozan Salim, Kaniye Aydın, Emel Gürkan, Orhan Kemal Yücel, Güray Saydam, Mehmet Ali Sungur
Publikováno v:
Balkan Medical Journal, Vol 32, Iss 4, Pp 347-351 (2015)
Background: Immune thrombocytopenia (ITP) is an autoimmune disorder. It is characterized by thrombocytopenia due to thrombocyte destruction mediated by autoantibodies; however, cytotoxic and defective regulatory T-lymphocytes play an important role i
Externí odkaz:
https://doaj.org/article/fa637621d6c14178bc38f1f18b90c909
Publikováno v:
Turkish Journal of Hematology, Vol 30, Iss 3, Pp 234-246 (2013)
Multiple myeloma is the second most common haematological malignancy. Novel therapies have led to improvement in survival. Current myeloma management is matching the progress made in improved survival through disease control while optimising quality
Externí odkaz:
https://doaj.org/article/3d3f0427686e423b87f735548af25b96
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 1 (2014)
Multiple myeloma is the second most common haematological malignancy and usually presents with bone pain, pathologic fractures and anemia. It may affects thorax as bone lesions, plasmocytomas, pulmonary infiltrations and pleural effusion. Pleural eff
Externí odkaz:
https://doaj.org/article/e1518fa33b664e41b0aa8588b5b9d185
Publikováno v:
In Clinical Lymphoma Myeloma and Leukemia August 2016 16 Supplement:S149-S151
Autor:
Özkan, Melda Cömert, Palamar, Melis, Tombuloğlu, Murat, Hekimgil, Mine, Özsan, Nazan, Saydam, Güray, Şahin, Fahri
Publikováno v:
In Clinical Lymphoma Myeloma and Leukemia June 2015 15 Supplement:S158-S160
Autor:
Dalgıç, Ceyda Tunakan, Kaymaz, Burçin Tezcanlı, Özkan, Melda Cömert, Dalmızrak, Ayşegül, Şahin, Fahri, Saydam, Güray
Publikováno v:
In Clinical Lymphoma Myeloma and Leukemia June 2015 15 Supplement:S161-S166